Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Keywords

Biology, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 2019-20 coronavirus outbreak, Coronavirus

References

• SARS corona virus peptides recognized by antibodies in the sera of convalescent casesJohn Fred Holly — 2004
• Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptorXing-Yi Ge, Jialu Li, Xing‐Lou Yang — 2013
• Transmission of MERS-coronavirus in household contacts.Christian Drosten, Benjamin Meyer, Marcel A. Müller — 2014
• Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern ChinaYi Guan, Bingxue Zheng, Yuxian He — 2003
• Evidence for camel-to-human transmission of MERS coronavirus.Esam I. Azhar, Sherif A. El‐Kafrawy, Suha A. Farraj — 2014
• CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.Scott A. Jeffers, Sonia M. Tusell, Laura Gillim-Ross — 2004
• Inferring the hosts of coronavirus using dual statistical models based on nucleotide compositionQin Tang, Yulong Song, Mijuan Shi — 2015
• Tracking the EpidemicMonica S. Ruiz, Alicia R. Gable, Edward H. Kaplan — 2001
• Structure, Function, and Evolution of Coronavirus Spike ProteinsFang Li — 2016
• Predicting the receptor-binding domain usage of the coronavirus based on kmer frequency on spike proteinZhaozhong Zhu, Zheng Zhang, Wenjun Chen — 2018
• Origin and evolution of pathogenic coronavirusesJie Cui, Fang Li, Zheng‐Li Shi — 2018
• From SARS to MERS, Thrusting Coronaviruses into the SpotlightZhiqi Song, Yanfeng Xu, Linlin Bao — 2019
• Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat originPeng Zhou, Xing‐Lou Yang, Xian-Guang Wang — 2020
• [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control].Xiang Gao, Wei-Chuan Chen, Lingchuan Guo — 2020

Cited by

• Molecular Modeling Evaluation of the Binding Effect of Ritonavir, Lopinavir and Darunavir to Severe Acute Respiratory Syndrome Coronavirus 2 ProteasesShen Lin, Runnan Shen, Jingdong He — 2020
• Clinical Characteristics of 2019 Novel Infected Coronavirus Pneumonia：A Systemic Review and Meta-analysisKai Qian, Yi Deng, Yonghang Tai — 2020
• Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assayWendong Hao, Manxiang Li — 2020
• Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV) ?Ping Liu, Jing‐Zhe Jiang, Xiu‐Feng Wan — 2020
• Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosisRobinson Sabino‐Silva, Ana Carolina Gomes Jardim, Walter L. Siqueira — 2020
• Functional pangenome analysis suggests inhibition of the protein E as a readily available therapy for COVID-2019Intikhab Álam, Allan Kamau, Maxat Kulmanov — 2020
• Molecular Dynamics Simulations Indicate the SARS-CoV-2 Mpro Is Not a Viable Target for Small-Molecule Inhibitors DesignMaria Bzówka, Karolina Mitusińska, Agata Raczyńska — 2020
• 2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, ChinaWei-Hsuan Huang, Ling-Chiao Teng, Ting‐Kuang Yeh — 2020
• Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)Changquan Ling — 2020
• Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2Zhixin Liu, Xiao Xiao, Xiuli Wei — 2020
• Candidate targets for immune responses to 2019-Novel Coronavirus (nCoV): sequence homology- and bioinformatic-based predictionsAlba Grifoni, John Sidney, Yun Zhang — 2020
• Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug designWioletta Rut, Katarzyna Groborz, Linlin Zhang — 2020
• Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunctionXiaoyan Liu, Zhe Li, Shuai Liu — 2020
• Novel Coronavirus Disease 2019 (COVID-19): An Emerging Infectious Disease in the 21st CenturyAhmad Tavakoli, Katayon Vahdat, Mohsen Keshavarz — 2020
• The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in ChinaYongshi Yang, Fujun Peng, Runsheng Wang — 2020
• The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Alexander E. Gorbalenya, Susan C. Baker, Ralph S. Baric — 2020
• On the origin and continuing evolution of SARS-CoV-2Xiaolu Tang, Changcheng Wu, Xiang Li — 2020
• The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei provinceJinwei Ai, Junwen Chen, Yong Wang — 2020
• The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencingMinfeng Liao, Yang Liu, Jin Yuan — 2020
• Coronavirus Disease 2019–COVID-19Kuldeep Dhama, Khan Sharun, Ruchi Tiwari — 2020

Related papers

• Wearing masks and the fight against the novel coronavirus (COVID-19)Javad Alizargar — 2020
• Treatment considerations for coronavirus (COVID-19)Joseph Reilly — 2020
• Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)Yuk Ming Dennis Lo, Rossa W. K. Chiu — 2020
• The reproductive number of COVID-19 is higher compared to SARS coronavirusYing Liu, Alberto Alexander Gayle, Annelies Wilder‐Smith — 2020
• And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nManFilipe Froes — 2020
• Coronavirus 2019-nCoV: Is the genie already out of the bottle?Thomas Hänscheid, Emília Valadas, Martin P. Grobusch — 2020
• Differential Household Attack Rates Mirror the Ability to Control Coronavirus Disease 2019 (COVID-19)Alex R. Cook, Borame Sue Lee Dickens, Annelies Wilder‐Smith — 2020